The presence of lymph node metastases is one of the most important prognostic factors after radical prostatectomy. However, not all patients with node-positive prostate cancer have the same risk of cancer-specific death and stratification can help identify those patients with few lymph node metastases who could expect a better prognosis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comparing nodal versus bony metastatic spread using tumour phylogenies
Scientific Reports Open Access 22 September 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Touijer, K. A., Mazzola, C. R., Sjoberg, D. D., Scardino, P. T. & Eastham, J. A. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur. Urol. 'http://dx.doi.org/10.1016/j.eururo.2013.03.053.
Briganti, A. et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive n + patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur. Urol. 55, 261–270 (2009).
Schiavina, R. et al. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score. BJU Int. http://dx.doi.org/10.1111/j.1464–1410X.2012.11602.x.
Edge, S. B. et al. (Eds) AJCC Cancer Staging Manual 7th edn (Springer, New York, 2010).
Carlsson, S. V. et al. Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer. J. Urol. 189, 1314–1319 (2013).
Zeng, Y., Opeskin, K., Goad, J. & Williams, E. D. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Cancer Res. 66, 9566–9575 (2006).
Bubendorf, L. et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum. Pathol. 31, 578–583 (2000).
Palmieri, F. et al. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy. Anticancer Res. 30, 2973–2976 (2010).
Brunocilla, E., Pernetti, R. & Martorana, G. The role of pelvic lymph node dissection during radical cystectomy for bladder cancer. Anticancer Res. 31, 271–275 (2011).
Nanni, C. et al. Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results. Eur. J. Nucl. Med. Mol. Imaging http://dx.doi.org/10.1007/s00259-013-2373-3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Schiavina, R., Brunocilla, E. Lymph node metastases: not always the same prognosis. Nat Rev Urol 10, 435–436 (2013). https://doi.org/10.1038/nrurol.2013.127
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2013.127
This article is cited by
-
Comparing nodal versus bony metastatic spread using tumour phylogenies
Scientific Reports (2016)
